ArticleFrontiers in nutrition2026
Effectiveness of whole grain to body weight and cardiometabolic risk in adults with obesity: a parallel randomised controlled trial.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objectives: Obesity is a global health problem associated with an increased risk of cardiovascular disease. Whole grains are thought to contribute to weight management and reduce cardiovascular risk factors. Methods: A parallel randomised controlled trial was conducted with 115 obese adults who were randomly assigned to one of two whole grain intervention groups (50 g and 100 g per day) or to control group. Results: The mean weight change from baseline to 12 weeks between the 50 g/d whole grain group and the control group was -2.0 kg (95% CI, -3.1 to -0.8), and -1.7 kg (95% CI, -2.7 to -0.6) between the 100 g/d whole grain group and the control group. Body-mass index (BMI), body fat and abdominal visceral fat also showed significant reductions in the whole grain groups compared to the control group. Fasting blood glucose and insulin resistance improved in both whole grain intervention groups. Additionally, triglycerides and total cholesterol levels and triglyceride glucose (TyG) index decreased significantly in the 50 and 100 g/d whole grain groups. Serum uric acid and homocysteine levels were observed in the 50 and 100 g/d whole grain groups with notable decreases compared to the control group. Conclusion: In adults with obesity, the whole grain intervention significantly improved weight loss and metabolic health. These findings support policies to increase whole grain consumption in the management of obesity. Clinical trial registration: www.chictr.org.cn, identifier: ChiCTR2300072952.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.